NIH and Exothera collaborate to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US
August 16, 2023
August 16, 2023
July 18, 2023
September 6, 2022
June 7, 2022
February 9, 2022
February 9, 2022
December 16, 2021
December 15, 2021
December 15, 2021
November 28, 2023
Patrick Thiaville, Nucleic Acids Chief Technology Officer at Exothera, a Univercells company and full-service Contract Development and Manufacturing O...
November 22, 2023
PrecisionLife®, a leading computational biology company focused on precision medicine in complex chronic diseases, announces the appointment of Dr Ger...
November 10, 2023
Medix Biochemica has acquired 100 percent of the shares of US-based ViroStat LLC, a global leader in infectious disease antibodies and antigens used b...
Life Science Newswire is a division of BioStrata.
BioStrata Ltd., Endurance House, Vision Park, Histon, Cambridge, CB249ZR,
Company registration: 8233225